Visit TheBody.com for Patient Education
You are not currently logged in.
Login
or
Register
Sign up for free e-mail/fax newsletters!
Now Live:
Breaking Research From XVII International AIDS Conference >>
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy
Antiretroviral Therapy
Acute Infection
Antiretrovirals
Assays (Diagnostic & Monitoring)
Guidelines
Initial Therapy
Pediatrics
Resistance
Salvage Therapy
Second/Third-Line Treatment
Structured Treatment Interruptions
Women & Pregnancy
More ...
Complications of HIV/HAART
Complications of HIV/HAART
Overview
Cardiovascular
Lipoatrophy
Gastrointestinal
Hepatitis
HPV & Cervical/Anal Cancer
Liver Complications
Malignancies
Mental Health
Metabolic
Neurocognitive
Renal Complications
Women-Specific
More ...
Research & Development
Research & Development
Overview
Antiretrovirals in Development
Conference Reports
HIV Genetics
HIV Immunology
More ...
Clinical Trials
Clinical Trials
Overview & News
U.S. Databases
U.S. Nationwide Studies
U.S. State-by-State Trial Listings
Databases Outside U.S.
Specific Trials Outside U.S.
More ...
Quality of Life & Patient Care
Quality of Life & Patient Care
Complementary Medicine
Mental Health
Primary Care
Mitochondrial Toxicity
Overview
|
Research
Overview
Does Mitochondrial Toxicity Drive Lipoatrophy?
(July 2003)
Highlights from the IAPAC Sessions 2003.
In
IAPAC Monthly
, from
International Association of Physicians in AIDS Care
Mitochondrial Toxicity and Lactic Acidosis Fact Sheet
(April 2001)
To read PDF,
click here
From
Project Inform
Research
ddI + Ribavirin May Cause Mitochondrial Toxicity
(September 1, 2005)
In
Journal of Acquired Immune Deficiency Syndromes
Ask the Expert: Case Study -- 38-Year-Old Woman With Persistent Flu-Like Symptoms
(June 2003)
To read PDF,
click here
In
HEPP Report
, from
Brown Medical School
Study Finds Protease Inhibitors May Help Cause Lipodystrophy
(October 30, 2002)
In
CDC HIV/Hepatitis/STD/TB Prevention News Update
, from
U.S. Centers for Disease Control and Prevention
The Case Against Zerit
(October 2002)
Research increasingly points to NRTIs -- particularly d4T -- as a likely culprit in metabolic disorders.
In
GMHC Treatment Issues
, from
Gay Men's Health Crisis
Mitochondrial Damage
(Fall 2002)
To read PDF,
click here
In
STEP Perspective
, from
Seattle Treatment Education Project
Mitochondrial Toxicity in HAART
(September 2002)
A review of the latest research.
In
The PRN Notebook